Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
$25 Million Gift to Penn Medicine and Children's Hospital of Philadelphia Establishes Center for Epilepsy and Neurodevelopmental Disorders
A $25 million gift from an anonymous donor to Penn Medicine and Children’s Hospital of […]
Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A501 Gene Therapy for Danon Disease
Rocket Pharmaceuticals, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic […]
Huma, Camden Health Partners and UCLPartners launch digital-first population health programme to identify and manage cardiovascular disease
Huma Therapeutics, a leading global digital health company, today announced a partnership with Camden Health […]
CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.
Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced the launch […]
TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials
TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, announces the final close of […]
Actinium Signs Cooperative Research and Development Agreement with National Cancer Institute
Actinium Pharmaceuticals, a leader in the development of targeted radiotherapies, have announced that it has […]
Roche Announces Positive Data from Global Phase III Programme for Crovalimab in PNH, a Rare Life-threatening Blood Condition
Roche has announced positive results from the global phase III COMMODORE 2 study, evaluating the […]
Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program
Radiology Imaging Associates (RIA), a division of RadNet, has announced that it has started the […]
Egret Therapeutics Receives FDA Clearance of IND Application for EGT 101 for Treatment of Delayed Cerebral Ischemia
Egret Therapeutics, a clinical-stage biotechnology company focused on developing transformative therapies for neurological conditions, has […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more